A mutation in the thrombomodulin gene, 127G to A coding for Ala25Thr, and the risk of myocardial infarction in men - PubMed (original) (raw)

Affiliations

PMID: 9843165

A mutation in the thrombomodulin gene, 127G to A coding for Ala25Thr, and the risk of myocardial infarction in men

C J Doggen et al. Thromb Haemost. 1998 Nov.

Abstract

Thrombomodulin is an endothelial cell surface receptor that transforms the procoagulant thrombin into an anticoagulant. A mutation in the thrombomodulin gene is a potential risk factor for venous and arterial thrombosis. We screened a region within the coding sequence of the thrombomodulin gene by single-strand conformation polymorphism analysis (SSCP) in a pilot study of 104 patients with myocardial infarction and 104 age, sex and race matched controls. We identified a 127G to A mutation in the gene, which predicts an Ala25Thr substitution, in 2 out of 104 patients (1 man and 1 woman) with myocardial infarction but in no controls. We assessed the risk of myocardial infarction associated with the mutation in a larger "Study of Myocardial Infarctions Leiden" (SMILE). Among 560 men with a first myocardial infarction before the age of 70, 12 were carriers of the Ala25Thr substitution. In a control group of 646 men, frequency-matched for age, seven were carriers of the Ala25Thr substitution. The allelic frequencies were 1.07% among patients and 0.54% among controls suggesting risk associated with the mutation [odds ratio (OR) 2.0, 95% confidence interval (CI) 0.8-5.1]. In patients aged below 50, the predicted risk was almost seven times increased (OR 6.5, CI 0.8-54.2). In the presence of additional risk factors, such as smoking and a metabolic risk factor, the predicted risk increased to 9-fold (OR 8.8. CI 1.8-42.2) and 4-fold (OR 4.4, CI 0.9-21.3), respectively. While not conclusive, these results strongly suggest that the Ala25Thr substitution is a risk factor for myocardial infarction, especially in young men, and when in the presence of additional risk factors.

PubMed Disclaimer

Cited by

Thrombomodulin and its role in inflammation.
Conway EM. Conway EM. Semin Immunopathol. 2012 Jan;34(1):107-25. doi: 10.1007/s00281-011-0282-8. Epub 2011 Jul 31. Semin Immunopathol. 2012. PMID: 21805323 Review.
Thrombomodulin mutations in atypical hemolytic-uremic syndrome.
Delvaeye M, Noris M, De Vriese A, Esmon CT, Esmon NL, Ferrell G, Del-Favero J, Plaisance S, Claes B, Lambrechts D, Zoja C, Remuzzi G, Conway EM. Delvaeye M, et al. N Engl J Med. 2009 Jul 23;361(4):345-57. doi: 10.1056/NEJMoa0810739. N Engl J Med. 2009. PMID: 19625716 Free PMC article.
Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment.
Tang Z, Tracy RP. Tang Z, et al. J Thromb Thrombolysis. 2001 Feb;11(1):49-81. doi: 10.1023/a:1008956327032. J Thromb Thrombolysis. 2001. PMID: 11248790 Review. No abstract available.
Thrombophilia, polymorphisms, and vascular disease.
Sykes TC, Fegan C, Mosquera D. Sykes TC, et al. Mol Pathol. 2000 Dec;53(6):300-6. doi: 10.1136/mp.53.6.300. Mol Pathol. 2000. PMID: 11193048 Free PMC article. Review.
Clinical, laboratory, and genetic risk factors for thrombosis in sickle cell disease.
Srisuwananukorn A, Raslan R, Zhang X, Shah BN, Han J, Gowhari M, Molokie RE, Gordeuk VR, Saraf SL. Srisuwananukorn A, et al. Blood Adv. 2020 May 12;4(9):1978-1986. doi: 10.1182/bloodadvances.2019001384. Blood Adv. 2020. PMID: 32384541 Free PMC article.

A mutation in the thrombomodulin gene, 127G to A coding for Ala25Thr, and the risk of myocardial infarction in men - PubMed (original) (raw)